HMOX1 and autoimmune hepatitis: Other studies have reported protective effects related to HO-1 expression after the exogenous administration of CORM in different experimental models of autoimmune diseases, including multiple sclerosis [63], type-1 diabetes [64], and autoimmune hepatitis [65].